Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioRestorative Therapies (BRTX) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to 3.98%.

  • BioRestorative Therapies' Return on Capital Employed fell 28600.0% to 3.98% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.98%, marking a year-over-year decrease of 28600.0%. This contributed to the annual value of 1.33% for FY2024, which is 500.0% down from last year.
  • As of Q3 2025, BioRestorative Therapies' Return on Capital Employed stood at 3.98%, which was down 28600.0% from 2.28% recorded in Q2 2025.
  • In the past 5 years, BioRestorative Therapies' Return on Capital Employed ranged from a high of 1.1% in Q2 2024 and a low of 13.98% during Q3 2021
  • Over the past 5 years, BioRestorative Therapies' median Return on Capital Employed value was 1.72% (recorded in 2025), while the average stood at 3.35%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first tumbled by -66300bps in 2021, then skyrocketed by 122700bps in 2022.
  • Over the past 5 years, BioRestorative Therapies' Return on Capital Employed (Quarter) stood at 2.2% in 2021, then increased by 23bps to 1.69% in 2022, then rose by 15bps to 1.44% in 2023, then increased by 17bps to 1.19% in 2024, then plummeted by -234bps to 3.98% in 2025.
  • Its last three reported values are 3.98% in Q3 2025, 2.28% for Q2 2025, and 1.72% during Q1 2025.